Lyell Immunopharma, Inc. (LYEL)

Import this data to Google Sheets with:

=jivedata("LYEL","financials")

Full statements spill as a table. For one cell: =jivedata("LYEL","Revenue") or =jivedata("LYEL","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Lyell Immunopharma, Inc.

LYEL • CIK 0001806952

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenues	$130	$61	$36	$27
Operating Income (Loss)	$-247,008	$-358,755	$-269,404	$-256,495
Interest Income (Expense), Nonoperating, Net	$23,453	$24,068	$13,080	$10,320
Other Nonoperating Income (Expense)	$1,846	$4,694	$-18,124	$-2,302
Equity Securities, FV-NI, Unrealized Loss	$12,923	$13,001	$0	$0
Nonoperating Income (Expense)	$12,376	$15,761	$-5,044	$8,018
Net Income (Loss) Attributable to Parent	$-234,632	$-342,994	$-274,448	$-248,477
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$-227,127	$-342,609	$-274,497	$-248,692
Weighted Average Number of Shares Outstanding, Basic	250,983,000	261,480,000	17,093,000	24,943,000
Research and Development Expense (Excluding Acquired in Process Cost)	—	$171,603	$158,675	$158,675
General and Administrative Expense	$66,983	$52,041	$45,135	$40,434
Other Operating Income (Expense), Net	$2,790	$3,309	$2,145	$6,743
Research and Development Asset Acquired Other than Through Business Combination, Written-off	—	$87,184	$66,332	$66,332
Impairment of Long-Lived Assets Held-for-use	$0	$51,297	$1,443	$0
Operating Expenses	$247,138	$358,816	$269,440	$256,522
OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax	$7,505	$385	$-49	$-215

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$145,647	$105,597	$60,181	$72,985
Marketable Securities, Current	$400,576	$264,930	$187,039	$131,117
Restricted Cash, Noncurrent	$284	$1,690	$1,585	$1,587
Prepaid Expense and Other Assets, Current	$8,463	$9,067	$13,719	$9,439
Marketable Securities, Noncurrent	$16,506	$13,014	$0	$23,896
Assets, Current	$554,686	$379,594	$260,939	$213,541
Other Investments	$32,001	$19,000	$19,000	$19,000
Property, Plant and Equipment, Net	$102,654	$48,200	$34,771	$30,507
Operating Lease, Right-of-Use Asset	$39,663	$24,739	$18,871	$16,781
Other Assets, Noncurrent	$4,235	$4,622	$4,886	$5,841
Assets	$750,029	$490,859	$340,052	$311,153
Operating Lease, Liability, Noncurrent	$56,894	$50,994	$41,921	$36,934
Other Liabilities, Noncurrent	$3,664	$3,253	$517	$537
Liabilities	$95,077	$108,035	$91,850	$77,338
Accounts Payable, Current	$4,817	$5,366	$2,893	$3,879
Accrued Liabilities and Other Liabilities	$28,126	$40,411	$46,519	$35,988
AssetAcquisitionContingentConsiderationLiabilityCurrent	—	$7,600	$0	$0
Liabilities, Current	$34,519	$53,788	$49,412	$39,867
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$25	$29	$2	$2
Additional Paid in Capital	$1,657,133	$1,727,610	$1,867,512	$1,922,433
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-94	$291	$242	$-158
Retained Earnings (Accumulated Deficit)	$-1,002,112	$-1,345,106	$-1,619,554	$-1,688,462
Stockholders' Equity Attributable to Parent	$654,952	$382,824	$248,202	$233,815
Preferred Stock, Shares Authorized	10,000,000	10,000,000	10,000,000	10,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	500,000,000	500,000,000	500,000,000	500,000,000
Common Stock, Shares, Issued	253,958,000	294,876,000	21,251,000	23,397,000
Common Stock, Shares, Outstanding	253,957,709	294,875,546	21,251,353	23,396,808

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$-234,632	$-342,994	$-274,448	$-248,477
Net Cash Provided by (Used in) Operating Activities	$-163,694	$-162,394	$-150,024	$-133,260
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$22,097	$-38,644	$-45,521	$-25,816
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$145,931	$107,287	$61,766	$32,106
Research and Development Asset Acquired Other than Through Business Combination, Written-off	—	$87,184	$66,332	$66,332
Payments to Acquire Property, Plant, and Equipment	$2,686	$464	$780	$711
Share-based Payment Arrangement, Noncash Expense	$47,084	$33,144	$41,829	$39,628
Proceeds from Sale of Property, Plant, and Equipment	—	—	$287	$292
Payments to Acquire Debt Securities, Available-for-sale	$476,880	$394,707	$278,899	$204,493
Depreciation, Depletion and Amortization	$20,250	$19,631	$11,539	$9,517
Proceeds from Sale and Maturity of Debt Securities, Available-for-sale	$663,614	$548,941	$374,684	$251,085
Accretion (Amortization) of Discounts and Premiums, Investments	$9,596	$14,681	$4,959	$3,777
Net Cash Provided by (Used in) Investing Activities	$184,048	$122,424	$54,097	$4,978
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property	$-1,509	$-1,341	$-3,344	$298
Impairment of Long-Lived Assets Held-for-use	$0	$51,297	$1,443	$0
Equity Securities, FV-NI, Unrealized Gain (Loss)	—	—	$-30	$-2
Proceeds from Issuance of Common Stock	—	—	$50,000	$50,000
Proceeds from Stock Options Exercised	$306	$154	$42	$68
Proceeds from Stock Plans	$1,894	$1,248	$365	$703
Payment, Tax Withholding, Share-based Payment Arrangement	$457	$76	$1	$1
Net Cash Provided by (Used in) Financing Activities	$1,743	$1,326	$50,406	$102,466
Cash and Cash Equivalents, at Carrying Value	$145,647	$105,597	$60,181	$30,623
Restricted Cash, Noncurrent	$284	$1,690	$1,585	$1,483
Increase (Decrease) in Prepaid Expense and Other Assets	$-3,125	$-1,775	$-2,823	$-1,352
Increase (Decrease) in Accounts Payable	$1,464	$-3,234	$-2,339	$465
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities	$-719	$-1,250	$-7,642	$6,517
Increase (Decrease) in Other Noncurrent Liabilities	$-449	$-411	$-2,736	$-2,493
AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable	—	$36,011	$33,972	$33,972
Capital Expenditures Incurred but Not yet Paid	$29	$144	$0	$68

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("LYEL","financials")

Full statements spill as a table. For one cell: =jivedata("LYEL","Revenue") or =jivedata("LYEL","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.